Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
Cell Stem Cell. 2020 Jun 4;26(6):832-844.e6. doi: 10.1016/j.stem.2020.04.008. Epub 2020 May 27.
Cell Stem Cell. 2020.
PMID: 32464096
Free article.
Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
Vora P, Seyfrid M, Venugopal C, Qazi MA, Salim S, Isserlin R, Subapanditha M, O'Farrell E, Mahendram S, Singh M, Bakhshinyan D, Chokshi C, McFarlane N, Dvorkin-Gheva A, Brown KR, Murty N, Moffat J, Bader GD, Singh SK.
Vora P, et al. Among authors: seyfrid m.
J Neurooncol. 2019 Jul;143(3):417-428. doi: 10.1007/s11060-019-03192-1. Epub 2019 May 21.
J Neurooncol. 2019.
PMID: 31115870
Item in Clipboard
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Seyfrid M, Maich WT, Shaikh VM, Tatari N, Upreti D, Piyasena D, Subapanditha M, Savage N, McKenna D, Mikolajewicz N, Han H, Chokshi C, Kuhlmann L, Khoo A, Salim SK, Archibong-Bassey B, Gwynne W, Brown K, Murtaza N, Bakhshinyan D, Vora P, Venugopal C, Moffat J, Kislinger T, Singh S.
Seyfrid M, et al.
J Immunother Cancer. 2022 Jan;10(1):e003289. doi: 10.1136/jitc-2021-003289.
J Immunother Cancer. 2022.
PMID: 35017149
Free PMC article.
Item in Clipboard
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.
Tatari N, Zhang X, Chafe SC, McKenna D, Lawson KA, Subapanditha M, Shaikh MV, Seyfrid M, Savage N, Venugopal C, Moffat J, Singh SK.
Tatari N, et al. Among authors: seyfrid m.
Front Immunol. 2022 Jul 6;13:905768. doi: 10.3389/fimmu.2022.905768. eCollection 2022.
Front Immunol. 2022.
PMID: 35874663
Free PMC article.
Item in Clipboard
In Vitro Self-Renewal Assays for Brain Tumor Stem Cells.
Seyfrid M, Bobrowski D, Bakhshinyan D, Tatari N, Venugopal C, Singh SK.
Seyfrid M, et al.
Methods Mol Biol. 2019;1869:79-84. doi: 10.1007/978-1-4939-8805-1_7.
Methods Mol Biol. 2019.
PMID: 30324515
Item in Clipboard
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.
Bakhshinyan D, Adile AA, Liu J, Gwynne WD, Suk Y, Custers S, Burns I, Singh M, McFarlane N, Subapanditha MK, Qazi MA, Vora P, Kameda-Smith MM, Savage N, Desmond KL, Tatari N, Tran D, Seyfrid M, Hope K, Bock NA, Venugopal C, Bader GD, Singh SK.
Bakhshinyan D, et al. Among authors: seyfrid m.
Sci Adv. 2021 Dec 10;7(50):eabi5568. doi: 10.1126/sciadv.abi5568. Epub 2021 Dec 8.
Sci Adv. 2021.
PMID: 34878832
Free PMC article.
Item in Clipboard
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.
Dirkse A, Golebiewska A, Buder T, Nazarov PV, Muller A, Poovathingal S, Brons NHC, Leite S, Sauvageot N, Sarkisjan D, Seyfrid M, Fritah S, Stieber D, Michelucci A, Hertel F, Herold-Mende C, Azuaje F, Skupin A, Bjerkvig R, Deutsch A, Voss-Böhme A, Niclou SP.
Dirkse A, et al. Among authors: seyfrid m.
Nat Commun. 2019 Apr 16;10(1):1787. doi: 10.1038/s41467-019-09853-z.
Nat Commun. 2019.
PMID: 30992437
Free PMC article.
Item in Clipboard
Reactive oxygen species contribute toward Smac mimetic/temozolomide-induced cell death in glioblastoma cells.
Seyfrid M, Marschall V, Fulda S.
Seyfrid M, et al.
Anticancer Drugs. 2016 Nov;27(10):953-959. doi: 10.1097/CAD.0000000000000412.
Anticancer Drugs. 2016.
PMID: 27669171
Item in Clipboard
Cite
Cite